Bupre/norphine OEM 10ng/Ml BUP Drug Test Cassette Dipstick Panel Rapid Testing

Product Specification

Buprenor/phine OEM BUP Drug Abuse Rapid Cassette/Dipstick/Panel Testing Kits With Easy-to-use
 

Applications:

The BUP Rapid Test (Urine) is a rapid chromatographic immunoassay for the detection of Bupre/norphine in human urine at a cut-off concentration of 5 ng/mL.

This assay provides only a qualitative, preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GC/MS) or Liquid Chromatography/mass spectrometry (LC/MS) are the preferred confirmatory methods.

Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are used.

Description:
 

Bupreno/rphine is a potent analgesic often used in the treatment of opioid addiction. The drug is sold under the trade names Subutex,™ Buprenex,™ Temgesic,™ and Suboxone™ which contain Bupreno/rphine HCl alone or in combination with Naloxone HCl.

Therapeutically, Bupren/orphine is used as a substitution treatment for opioid addicts. Substitution treatment is a form of medical care offered to opiate addicts (primarily her/oin addicts) based on a similar or identical substance to the drug normally used. In substitution therapy, Bupren/orphine is as effective as Metha/done but demonstrates a lower level of physical dependence. Concentrations of free Bupre/norphine and Norbu/prenorphine in urine may be less than 1 ng/mL after therapeutic administration, but can range up to 20 ng/mL in abuse situations.

The plasma half-life of Bupre/norphine is 2-4 hours.1 While complete elimination of a single-dose of the drug can take as long as 6 days, the detection window for the parent drug in urine is thought to be approximately 3 days.

How to use?

Allow the test, urine specimen, and/or controls to reach room temperature (15-30°C) prior to testing.
1. Bring the pouch to room temperature before opening it. Remove the test cassette from the sealed pouch and use it within one hour.

2. Place the test cassette on a clean and level surface. Hold the dropper vertically and transfer 3 full drops of urine (approx. 120μL) to the specimen well (S) of the test cassette, and then start the timer. Avoid trapping air bubbles in the specimen well (S). See the illustration below.

3. Wait for the colored line(s) to appear. Read results at 5 minutes. Do not interpret the result after 10minutes.

DIRECTIONS FOR PANEL USE

Allow the test, urine specimen, and/or controls to reach room temperature (15-30ºC) prior to testing.
1. Bring the pouch to room temperature before opening it. Remove the test panel from the sealed pouch and use it within one hour.

2. Remove the cap.

3. With the arrow pointing toward the urine specimen, immerse the test panel vertically in the urine specimen for at least 10 to 15 seconds. Immerse the strip to at least the level of the wavy lines, but not above the arrow on the test panel.

4. Replace the cap and place the test panel on a non-absorbent flat surface.

5. Start the timer and wait for the colored line(s) to appear.

6. The result should be read at 5 minutes. Do not interpret the result after 10 minutes.

DIRECTIONS FOR DIPSTICK USE

Allow the test, urine specimen, and/or controls to reach room temperature (15-30ºC) prior to testing.
1. Bring the pouch to room temperature before opening it. Remove the test dipstick from the sealed pouch and use it within one hour.

2. With arrows pointing toward the urine specimen, immerse the test dipstick vertically in the urine specimen for at least 10-15 seconds. Do not pass the maximum line (MAX) on the Test Dipstick when immersing the strip. See the illustration below.

3. Place the test dipstick on a non-absorbent flat surface, start the timer and wait for the colored line(s) to appear. Read results at 5 minutes. Do not interpret the result after 10 minutes.

INTERPRETATION OF RESULTS

(Please refer to the illustration above)

NEGATIVE:* Two lines appear. One colored line should be in the control line region (C), and another apparent colored line should be in the test line region (T). This negative result indicates that the Bupre/norphine (BUP) concentration is below the detectable cut-off level.

*NOTE: The shade of color in the test line region (T) may vary, but it should be considered negative whenever there is even a faint colored line.

POSITIVE: One colored line appears in the control line region (C). No line appears in the test line region (T). This positive result indicates that the Bupreno/rphine (BUP) exceeds the detectable cut-off level.

INVALID: Control line fails to appear. Insufficient specimen volume or incorrect procedural techniques are the most likely reasons for control line failure. Review the procedure and repeat the test with a new test. If the problem persists, discontinue using the test kit immediately and contact your local distributor.

Order Information